RankingsPricing
  1. JP-listed companies
  2. Kidswell Bio Corporation
  3. Financials
  4. Net income

Kidswell Bio Corporation【JP:4584】

Market cap
¥11.1B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 2025-21-98.51%
Mar 31, 2024-1,422+116.31%
Mar 31, 2023-657+22.83%
Mar 31, 2022-535-46.55%
Mar 31, 2021-1,001-86.31%
Mar 31, 2020-7,316+754.43%
Mar 31, 2019-856-5.34%
Mar 31, 2018-905-26.13%
Mar 31, 2017-1,225+55.46%
Mar 31, 2016-788-0.57%
Mar 31, 2015-792+52.55%
Mar 31, 2014-519+37.73%
Mar 31, 2013-377+17.46%
Mar 31, 2012-321

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)